Sana Biotechnology SANA Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's other non-current liabilities?
- Sana Biotechnology (SANA) reported other non-current liabilities of $9.81M in Q1 2026.
- How has Sana Biotechnology's other non-current liabilities changed year-over-year?
- Sana Biotechnology's other non-current liabilities increased by 3.8% year-over-year, from $9.44M to $9.81M.
- What is the long-term trend for Sana Biotechnology's other non-current liabilities?
- Over 2 years (2020 to 2025), Sana Biotechnology's other non-current liabilities has grown at a 343.1% compound annual growth rate (CAGR), from $540K to $10.6M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.